"The guest highlighted a successful research monetization pathway where the Stowers Institute discovered a biological mechanism to reverse osteoporosis and sold the technology to Amgen."

"The guest argued that China has surpassed the United States in clinical trial volume and novel drug development, shifting the global center of gravity for biotechnology."